Market Cap ₹902 Cr.
Stock P/E 0.0
P/B 47.5
Current Price ₹563.2
Book Value ₹ 11.9
Face Value 10
52W High ₹730
Dividend Yield 0%
52W Low ₹ 211
Vasa Denticity Ltd is a dynamic and innovative company specializing in advanced dental solutions. With a commitment to revolutionizing oral healthcare, Vasa Denticity combines cutting-edge technology, skilled professionals, and a patient-centered approach to deliver exceptional dental services. The company offers a comprehensive range of dental treatments, including general dentistry, cosmetic dentistry, orthodontics, oral surgery, and implantology. Using state-of-the-art equipment and advanced techniques, Vasa Denticity ensures precise diagnoses, efficient procedures, and optimal patient comfort. Vasa Denticity prides itself on its highly qualified and experienced team of dentists, hygienists, and support staff who are dedicated to providing personalized care and outstanding results. The company prioritizes ongoing education and professional development to stay at the forefront of dental advancements. Committed to fostering long-term relationships with patients, Vasa Denticity emphasizes open communication, transparency, and empathy throughout the treatment journey. Their mission is to enhance smiles, improve oral health, and ultimately enhance the overall well-being of their patients.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|
| Net Sales | 30 | 40 | 77 | 123 | |
| Other Income | 0 | 0 | 0 | 1 | |
| Total Income | 30 | 40 | 77 | 124 | |
| Total Expenditure | 30 | 40 | 71 | 113 | |
| Operating Profit | 0 | 1 | 6 | 11 | |
| Interest | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 1 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 0 | 0 | 5 | 10 | |
| Provision for Tax | -0 | 0 | 0 | 2 | |
| Profit After Tax | 0 | 0 | 5 | 8 | |
| Adjustments | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 0 | 0 | 5 | 8 | |
| Adjusted Earnings Per Share | 0.1 | 0.3 | 4.1 | 5.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 60% | 60% | 0% | 0% |
| Operating Profit CAGR | 83% | 0% | 0% | 0% |
| PAT CAGR | 60% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 71% | 101% | 85% | 85% |
| ROCE Average | 80% | 68% | 56% | 56% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Shareholder's Funds | 0 | 1 | 6 | 16 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 1 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 1 |
| Total Current Liabilities | 4 | 6 | 11 | 13 |
| Total Liabilities | 5 | 7 | 19 | 29 |
| Fixed Assets | 0 | 0 | 1 | 2 |
| Other Non-Current Assets | 0 | 0 | 1 | 3 |
| Total Current Assets | 4 | 6 | 17 | 25 |
| Total Assets | 5 | 7 | 19 | 29 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 1 |
| Cash Flow from Operating Activities | 1 | -0 | 0 | 2 |
| Cash Flow from Investing Activities | -0 | -1 | -0 | -1 |
| Cash Flow from Financing Activities | -0 | 1 | 1 | -0 |
| Net Cash Inflow / Outflow | 0 | -0 | 1 | 1 |
| Closing Cash & Cash Equivalent | 0 | 0 | 1 | 1 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.08 | 0.27 | 4.1 | 5.92 |
| CEPS(Rs) | 0.14 | 0.34 | 4.35 | 6.34 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 0.22 | 0.49 | 4.69 | 12.32 |
| Core EBITDA Margin(%) | 0.75 | 1.23 | 7.26 | 8.4 |
| EBIT Margin(%) | 0.6 | 1.27 | 7.14 | 8.4 |
| Pre Tax Margin(%) | 0.31 | 1.1 | 6.52 | 8.07 |
| PAT Margin (%) | 0.31 | 0.81 | 6.49 | 6.17 |
| Cash Profit Margin (%) | 0.57 | 1.04 | 6.9 | 6.6 |
| ROA(%) | 1.98 | 5.62 | 38.46 | 31.47 |
| ROE(%) | 34.71 | 74.91 | 157.99 | 70.53 |
| ROCE(%) | 19.95 | 29.07 | 95.04 | 80.11 |
| Receivable days | 9.58 | 7.1 | 5.03 | 3.46 |
| Inventory Days | 27.46 | 23.07 | 30.15 | 41.03 |
| Payable days | 43.76 | 30.96 | 24.95 | 24.05 |
| PER(x) | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.01 | 0.03 | 0.02 | 0.1 |
| EV/Core EBITDA(x) | 1.34 | 1.72 | 0.33 | 1.14 |
| Net Sales Growth(%) | 0 | 31.73 | 91.96 | 60.25 |
| EBIT Growth(%) | 0 | 176.84 | 983.72 | 88.39 |
| PAT Growth(%) | 0 | 245.13 | 1433.43 | 52.14 |
| EPS Growth(%) | 0 | 245.13 | 1433.43 | 44.53 |
| Debt/Equity(x) | 2.37 | 3.3 | 0.57 | 0.06 |
| Current Ratio(x) | 1.02 | 1.05 | 1.49 | 1.96 |
| Quick Ratio(x) | 0.49 | 0.59 | 0.63 | 0.54 |
| Interest Cover(x) | 2.06 | 7.9 | 11.48 | 26.11 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Jun 2023 | Sep 2023 | Mar 2024 |
|---|---|---|---|
| Promoter | 69.62 | 69.62 | 69.62 |
| FII | 2.61 | 0 | 0 |
| DII | 2.25 | 1.69 | 0.65 |
| Public | 25.53 | 28.69 | 29.73 |
| Others | 0 | 0 | 0 |
| Total | 100 | 100 | 100 |
| # | Jun 2023 | Sep 2023 | Mar 2024 |
|---|---|---|---|
| Promoter | 1.12 | 1.12 | 1.12 |
| FII | 0.04 | 0 | 0 |
| DII | 0.04 | 0.03 | 0.01 |
| Public | 0.41 | 0.46 | 0.48 |
| Others | 0 | 0 | 0 |
| Total | 1.6 | 1.6 | 1.6 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
